Señales en vivo de 6MK.DE | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:35):

Stats
Volumen de hoy	748.00
Volumen promedio	926.00
Capitalización de mercado	300.88B
EPS	€0 ( 2024-04-24 )
Próxima fecha de ganancias	( €0 ) 2024-05-28
Last Dividend	€0.730 ( 2023-09-14 )
Next Dividend	€0 ( N/A )
P/E	143.13
ATR14	€0.579 (0.49%)

Merck & Co Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Merck & Co Inc Finanzas

Annual	2023
Ingresos:	€60.12B
Beneficio Bruto:	€43.99B (73.17 %)
EPS:	€0.140

FY	2023
Ingresos:	€60.12B
Beneficio Bruto:	€43.99B (73.17 %)
EPS:	€0.140

FY	2022
Ingresos:	€59.28B
Beneficio Bruto:	€41.87B (70.63 %)
EPS:	€5.72

FY	2021
Ingresos:	€48.70B
Beneficio Bruto:	€35.08B (72.02 %)
EPS:	€5.14

Financial Reports:

No articles found.

Merck & Co Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0.690 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0.730 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Merck & Co Inc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 3.16 - low (5.43%) | Divividend Growth Potential Score: 6.70 - Stable (34.05%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.380	2009-12-11
Last Dividend	€0.730	2023-09-14
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	56	--
Total Paid Out	€28.56	--
Avg. Dividend % Per Year	0.00%	--
Score	3.54	--
Div. Sustainability Score	3.16
Div.Growth Potential Score	6.70
Div. Directional Score	4.93	--

Next Divdend (Est)
(2024-07-01)

€0.745 Estimate 22.11 %

Dividend Stability

0.59 Average

Dividend Score

3.54

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
IC1B.F	Ex Dividend Junior	2023-08-31	Annually	0.00%
SYZ.DE	Ex Dividend Junior	2023-07-12	Annually	0.00%
CIS.DE	Ex Dividend Knight	2023-10-03	Quarterly	0.00%
LLY.DE	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
VOS.DE	Ex Dividend Junior	2023-05-25	Sporadic	0.00%
EBA.DE	Ex Dividend Knight	2023-08-31	Quarterly	0.00%
NVD.DE	Ex Dividend Knight	2023-09-06	Quarterly	0.00%
8GM.DE	Ex Dividend Knight	2023-08-31	Semi-Annually	0.00%
GDX.DE	Ex Dividend Knight	2023-10-05	Quarterly	0.00%
R66.DE	Ex Dividend Knight	2023-08-17	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0376	1.500	9.25	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0595	1.500	-0.451	-0.676	[0.1 - 1]
payoutRatioTTM	2.42	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.41	1.000	8.74	8.74	[3 - 30]
operatingCashFlowPerShareTTM	4.58	2.00	8.47	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.46	2.00	8.27	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.746	1.000	0.908	0.908	[0.2 - 0.8]
operatingProfitMarginTTM	0.0944	1.000	-0.111	-0.111	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.16

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	141.23	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.0595	2.50	-0.290	-0.676	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.46	2.00	8.85	10.00	[0 - 30]
dividendYielPercentageTTM	2.35	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.58	2.00	8.47	10.00	[0 - 30]
payoutRatioTTM	2.42	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	7.08	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.190	1.000	7.75	0	[0.1 - 0.5]
Total Score				6.70

Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.